Gentian Diagnostics ASA (OSL:GENT)
58.40
0.00 (0.00%)
Jul 11, 2025, 4:25 PM CET
Gentian Diagnostics ASA Revenue
Gentian Diagnostics ASA had revenue of 43.57M NOK in the quarter ending June 30, 2025, with 13.88% growth. This brings the company's revenue in the last twelve months to 163.38M, up 11.68% year-over-year. In the year 2024, Gentian Diagnostics ASA had annual revenue of 152.07M with 12.52% growth.
Revenue (ttm)
163.38M
Revenue Growth
+11.68%
P/S Ratio
5.51
Revenue / Employee
2.59M
Employees
63
Market Cap
900.67M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 152.07M | 16.92M | 12.52% |
Dec 31, 2023 | 135.15M | 23.23M | 20.76% |
Dec 31, 2022 | 111.92M | 11.91M | 11.91% |
Dec 31, 2021 | 100.01M | 21.13M | 26.78% |
Dec 31, 2020 | 78.88M | 23.50M | 42.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 603.92M |
Nordhealth AS | 545.88M |
Photocure ASA | 532.69M |
Vistin Pharma ASA | 440.66M |
Omda AS | 442.14M |
ArcticZymes Technologies ASA | 102.97M |
Lytix Biopharma AS | 608.00K |
Nykode Therapeutics AS | 87.09M |